lol @ the normalized earnings after the Vioxx write down, that is just pathetic IMO. There won't be a Vioxx case every year that they'll profit from in normal circumstances.
ROE declining, sits at about 10% now. I wonder what their ROC is with all the debt they have? It's probably lucky to be above their cost of capital, it's too close for comfort IMO.
